NIXT yields 1.53% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, NIXT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NIXT + JNJ for your $10,000?
NIXT tracks an index of recently deleted US small- and mid-cap stocks screened for quality. The portfolio aims to benefit from a potential long-term reversal in the performance of these deleted stocks. The index is constructed from a pool of the top 1000 and top 500 US companies in the RAFI Global Equity Investable Universe (GEIU), which are maintained in two benchmark indices, the Cap-Weight 500 and Cap-Weight 1000. Using a five-year look-back period, the smallest stocks or those that have fallen out of the benchmark indices are identified, scored, and ranked for quality using the following metrics: debt coverage ratio, equity issuance, debt issuance, change in leverage, total payout, and net payout. The top 80% are added to the index and are equally weighted. Companies in the index have a 5-year holding period and are removed if their market cap has risen enough to re-qualify for the benchmark indexes. The index is reconstituted annually in April and rebalanced in May.
Full NIXT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.